Covid Vaccination Argentina

10 July 2021 by Andres Klipphan
Why does Argentina need to return 811,000 vaccines that arrived from Mexico as donations in the coming months? A resolution of the Ministry of Health of the Nation reveals that the batch of AstraZeneca doses sent by President Andrés Manuel López Obrador have a "return charge." The details of the agreement that Alberto Fernánez sealed during his official visit in February.

The announcement of the arrival of the shipment of 811,000 doses of vaccine from the AstraZeneca laboratory from Mexico, on June 12, has an undisclosed story. There are details agreed between the Argentine President and his Mexican counterpart that so far have not taken public status, but were endorsed in a resolution of the Ministry of Health 24 hours before the Aeroméxico plane was received at the Ezeiza International Airport by Carla Vizzotti in person.

The point not communicated to society is that the vaccines "donated" by the Mexican State have a "return charge." That is, in the coming months Alberto Fernández will have to reintegrate to his counterpart Andrés Manuel López Obrador the same amount of vaccines that were “redirected” to our country from Mexico, given the delay in the immunization schedule for which Fernández received strong criticism.

In the information made public that the Ministry of Health circulated through the press releases, it was stated: "The 811,000 doses will be the first shipment released from Mexico that is part of the bilateral agreement for the production of the active ingredient in Argentina and later formulated and packaged in that country"....In any statement, in any interview, did the officials mention that our country should return the vaccines to Mexico....
 

Sputnik V: the Government approved the trust for USD 85 million for Laboratorios Richmond to finance its new vaccine plant The factory will be built in Pilar, in the province of Buenos Aires, and will be ready in the second half of 2022. They could also be generated there messenger RNA vaccines, such as those from Pfizer and Moderna
 
12 July 2021 at 4:31pm
How effective is the Sputnik V vaccine: the new revelations from an Argentine study.
Persons who had Covid-19 generated ten times more neutralizing antibodies after the first dose of the Sputnik V coronavirus vaccine than those who received the full scheme, confirmed a study carried out by the Ministry of Health of the Province of Buenos Aires and Conicet researchers, recently published in the international journal "Cell Reports Medicine".

The study:
(https://www.sciencedirect.com/science/article/pii/S2666379121002081) also found that 94% of the people who received the first dose and who had
not previously had the virus generated a strong IgG antibody response and the figure rose to 100% after completing the two-dose schedule. The authors of the study, led by Andrea Gamarnik, head of the Molecular Virology Laboratory of the Fundación Instituto Leloir (FIL) and senior researcher at Conicet, also verified that in those patients with a history of Covid-19, the second dose "does not produce additional benefits in terms of the antibody response." This is the first study on the immune response induced by this vaccine carried out outside of Russia and published in a journal after its peer review....
 
13 July 2021 at 9:41am
Vaccination in the City: in the coming days the second doses of Sinopharm will be applied to about 50,000 porteños. The Minister of Health of CABA, Fernán Quirós, also highlighted the importance of tourists carrying out a strict quarantine, isolated, to delay the community circulation of the Delta variant of the coronavirus.

“All the people who have received Sinopharm between the 21st and the 28th will be invited to be vaccinated. Surely between Wednesday and Friday of this week we will be inviting a group of about 50 thousand people who meet this criterion these days ”, said Dr. Quirós....
 

Another vaccination "strategy" that makes one go "hmm".
Ruling politicians who rushed to release prisoners to keep them "safe" from COVID are now in no rush to vaccinate those remaining in prisons to keep them safe from COVID (or make it safe for others to return) despite many of these prisoners having the same age and risk factors as members of the general population who have received vaccines.
 

"The courts ordered the vaccination of all prisoners at risk in Buenos Aires jails and police stations. The ruling was issued based on a collective legal action promoted by the Buenos Aires Human Rights Secretariat and the Provincial Memory Commission. The court gave the Kicillof administration five days to put together an inoculation plan". Seems like an ok vaccination strategy.

I'm with that, whatever you think of criminals, they can spread the virus perhaps even more effectively than other citizens, especially in jail, and in any case, they weren't sentenced to death.
 
14 July 2021 by Raul Kollmann
Vaccine Production in ARG: Quality Control, Authorizations and Imminent Contracts. Argentine vaccine production is making great strides and on several fronts. This Thursday the Gamaleya Institute would approve the quality control of 1,300,000 1st doses of the Sputnik vaccine completed by the Richmond Laboratory in ARG. The doses require authorization from the ANMAT so they would not be available this week but perhaps the next. The following step is the authorization of 1,050,000 2nd doses. In Russia they consider it a priority and opens the chance that quality control will be passed before the end of the month.

In parallel, Minister Carla Vizzotti and Presidential Advisor Cecilia Nicolini are talking in London and Oxford with the AstraZeneca Laboratory so it is produced in ARG, which is the fundamental and most complex part, but also the local completion of the product. It will not be easy, but it is surely a strategic plan for 2022. And the third initiative is the completion in ARG of the Sinopharm product which is being sought out. The process with the Sinergium Laboratory is well advanced and the first doses could be available in October. It is also a strategic move, especially if, as expected, Sinopharm is authorized for minors....
The objective is always the same: to achieve independence in the production of vaccines, with negotiations and projects at various ends - which includes dialogues for the Soberana and Abdala, two Cuban vaccines - aiming that the entire process can be completed in Argentina.

It is always taken into account that it is very possible that in 2022 another dose will have to be applied or that other variants will appear that require new adjustments in vaccination. And it appears likely that Richmond, mAbxience and Sinergium aim to produce, not only for ARG, but for the entire continent and even countries on other continents.
 
14 July 2021 at 7:06am
A quarter dose of Moderna's vaccine could elicit a large immune response. According to research published in the scientific journal Nature, there is the possibility of administering divided doses that could help address the world's vaccine shortage.

According to a study, which was performed in nearly 30 people, two injections each containing just a quarter of the standard dose of Modern Covid-19 vaccine resulted in long-lasting protective antibodies and T cells that they fight viruses. Thus, the results of the study, which has not yet been peer-reviewed, reveal the possibility of administering divided doses to stretch scarce vaccine supplies and accelerate the global immunization process....
....Another such trial is ongoing: a study in Belgium is comparing a lower dose version of the Pfizer - BioNTech vaccine with the standard dose....
 
Interesting news about the quarter-dose of Moderna, it remains to be seen how the company will manage it in practice. When it was discovered that it was possible to an extra 6th dose of Pfizer out of the standard 5-dose vial, Pfizer either charged for the extra dose, or reduced the vaccine deliveries to account for it (plus, an special "low dead-volume" syringe is needed to get the 6th dose). Don't count the eggs before they're hatched, as it were.
 
Back
Top